You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動丨上海萊士跌4.67% 百億收購案獲批 目標公司200億元商譽或成隱憂
格隆匯 11-15 15:10
格隆匯11月15日丨上海萊士(002252.SZ)本週三晚間公告稱,公司斥資132.46億元收購基立福公司所持有的Grifols Diagnostic SolutionsInc.(簡稱GDS)45%股權的併購計劃獲得有條件通過。上海萊士(002252.SZ)於昨日復牌後收跌4.11%,今日再度下跌4.67%,報7.56元,總市值376億元。基立福為西班牙上市公司,是全球血液製品行業的領導者,標的公司GDS為基立福從事血液檢測業務的子公司,是全球知名的血液檢測儀器及試劑的生產商,主要進行核酸檢測試劑和設備的銷售,以及免疫抗原、血型檢測產品的生產和銷售。就近兩年的數據來看,GDS的盈利能力還不錯,有助於增厚上市公司的業績。不過這筆交易本身也存在着一些隱憂。截至2019年6月末,GDS商譽賬面價值為199.61億元,佔期末總資產比重為72.66%,佔淨資產比重為80.68%,未來若標的公司因經營不善計提大額的商譽減值,可能影響上市公司當期投資收益。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account